Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-21-004949
Date:2021-07-13
Issuer: G1 THERAPEUTICS, INC. (GTHX)
Original Submission Date:

Reporting Person:

VELLECA MARK A.
700 PARK OFFICES DRIVE, SUITE 200
RESEARCH TRIANGLE PARK, NC 27709

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-07-13 M 10,000 a $0.39 71,000 direct
COMMON STOCK 2021-07-13 S 10,000 d $19.45 61,000 direct
COMMON STOCK 2021-07-14 M 10,000 a $0.39 71,000 direct
COMMON STOCK 2021-07-14 S 10,000 d $19.08 61,000 direct
COMMON STOCK 2021-07-15 M 10,000 a $0.39 71,000 direct
COMMON STOCK 2021-07-15 S 10,000 d $18.49 61,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 0.39 2021-07-13 deemed execution date M 10,000 (d) 2024-05-09 common stock 10,000 $0.39 247,286 direct
STOCK OPTIONS (RIGHT TO BUY) 0.39 2021-07-14 deemed execution date M 10,000 (d) 2024-05-09 common stock 10,000 $0.39 237,286 direct
STOCK OPTIONS (RIGHT TO BUY) 0.39 2021-07-15 deemed execution date M 10,000 (d) 2024-05-09 common stock 10,000 $0.39 227,286 direct
Footnotes
IDfootnote
f1 this sale was effected pursuant to a rule 10b5-1 trading plan.
f2 the price represents the weighted average price with a low of $19.25 and a high of $19.85. the reporting person undertakes to provide g1 therapeutics, inc., any security holder of g1 therapeutics, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this form 4.
f3 the price represents the weighted average price with a low of $18.90 and a high of $19.22. the reporting person undertakes to provide g1 therapeutics, inc., any security holder of g1 therapeutics, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this form 4.
f4 the price represents the weighted average price with a low of $18.29 and a high of $18.64. the reporting person undertakes to provide g1 therapeutics, inc., any security holder of g1 therapeutics, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this form 4.
f5 all shares underlying this option have vested.
WhaleWisdom Logo

Elevate your investments